Search

Your search keyword '"A. Sebio Garcia"' showing total 94 results

Search Constraints

Start Over You searched for: Author "A. Sebio Garcia" Remove constraint Author: "A. Sebio Garcia"
94 results on '"A. Sebio Garcia"'

Search Results

1. Prehabilitation in Patients With Breast Cancer Receiving Neoadjuvant Therapy to Minimize Musculoskeletal Postoperative Complications and Enhance Recovery (PREOPtimize): A Protocol for a Randomized Controlled Trial

5. Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery:The PREHAB Randomized Clinical Trial

7. Repeatability and learning effect in the 6MWT in preoperative cancer patients undergoing a prehabilitation program

8. Short-term effects of two different recovery strategies on muscle contractile properties in healthy active men: A randomised cross-over study

10. Actionable factors fostering scalability of prehabilitation

11. 350P Postoperative histopathological, clinical and molecular risk score for patients with colorectal liver metastases

13. 1742P Factors influencing awareness of patient associations in sarcoma: A multicentric cross-sectional study

15. Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery: The PREHAB Randomized Clinical Trial.

21. 1552P Magnitude of clinical benefit of cancer drugs used in advanced soft tissue sarcomas and GIST

22. Systematic review of the effect of aquatic therapeutic exercise in breast cancer survivors

23. Estudio Farmacogenético En Pacientes Con Carcinoma Rectal Tratados Con Quimorradioterapia Neoadyuvante Basada En Capecitabina

24. 76MO Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas

25. Brain metastases in colorectal cancer: prognostic factors and survival analysis

26. Association between the 6MWT and other measurements of physical functioning in patients with cancer awaiting major surgery.

27. 1638P Are all leiomyosarcomas created equal? Clinical characteristics and experience of a single reference centre

29. 412P Surgery and stereotactic ablative body radiotherapy for colorectal cancer lung oligometastases: One centre experience

30. 1552P Magnitude of clinical benefit of cancer drugs used in advanced soft tissue sarcomas and GIST

31. Short-term effects of two different recovery strategies on muscle contractile properties in healthy active men: A randomised cross-over study.

32. Systematic review of the effect of aquatic therapeutic exercise in breast cancer survivors.

33. Preoperative exercise training prevents functional decline after lung resection surgery: a randomized, single-blind controlled trial

34. 1638P Are all leiomyosarcomas created equal? Clinical characteristics and experience of a single reference centre

35. 451P Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients

37. OP V – 1 Prenatal exposure to organochlorine compounds and lung function until early adulthood

38. Prenatal exposure to organochlorine compounds and lung function until early adulthood

39. Clinicopathologic features and long-term follow-up of metastatic gastrointestinal stromal tumor (GIST) patients (pts) with durable response (> 5 years) to frontline imatinib (IM): A case-control study from GEIS

40. Validation of GAME score risk groups in resected colorectal cancer liver metastases and the prognostic relevance of KRAS, NRAS and BRAF mutation analysis

42. Preliminary efficacy of preoperative exercise training in patients with lung malignancies undergoing VATS

43. Ventilatory pattern in chronic stroke survivors

44. Association of immune-related adverse (irAEs) with immune-checkpoint inhibitors (ICIs) efficacy in solid tumors

45. Prognostic factors and specific populations in the pharmacogenetic randomized phase II trial of FOLFIRI with high-dose (HD) of irinotecan vs standard doses in metastatic colorectal cancer (mCRC) patients (pts) according to UGT1A1 genotype

46. Clinicopathologic features and long-term follow-up of metastatic gastrointestinal stromal tumor (GIST) patients (pts) with durable response (≥ 5 years) to frontline imatinib (IM): A case-control study from GEIS

47. Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis

48. Prognostic factors and specific populations in the pharmacogenetic randomized phase II trial of FOLFIRI with high-dose (HD) of irinotecan vs standard doses in metastatic colorectal cancer (mCRC) patients (pts) according to UGT1A1 genotype

Catalog

Books, media, physical & digital resources